Compare SLN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLN | MED |
|---|---|---|
| Founded | 1994 | 1980 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.4M | 120.6M |
| IPO Year | N/A | N/A |
| Metric | SLN | MED |
|---|---|---|
| Price | $6.37 | $12.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $39.67 | $16.50 |
| AVG Volume (30 Days) | ★ 305.5K | 236.8K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $25,830,000.00 | ★ $429,695,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $619.39 |
| Revenue Growth | ★ 40.39 | N/A |
| 52 Week Low | $1.97 | $10.36 |
| 52 Week High | $8.08 | $21.11 |
| Indicator | SLN | MED |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 66.06 |
| Support Level | $5.95 | $10.72 |
| Resistance Level | $6.60 | $11.12 |
| Average True Range (ATR) | 0.53 | 0.35 |
| MACD | -0.04 | 0.22 |
| Stochastic Oscillator | 29.81 | 94.57 |
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.